{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T23:31:44Z","timestamp":1722468704593},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,12,16]],"date-time":"2012-12-16T00:00:00Z","timestamp":1355616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00702-012-0946-0","type":"journal-article","created":{"date-parts":[[2012,12,14]],"date-time":"2012-12-14T23:03:53Z","timestamp":1355526233000},"page":"347-348","source":"Crossref","is-referenced-by-count":4,"title":["Is there room for non-dopaminergic treatment in Parkinson disease?"],"prefix":"10.1007","volume":"120","author":[{"given":"Abraham","family":"Lieberman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narayanan","family":"Krishnamurthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,16]]},"reference":[{"issue":"3\u20134","key":"946_CR1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF01252816","volume":"58","author":"W Birkmayer","year":"1983","unstructured":"Birkmayer W, Birkmayer G, Lechner H, Riederer P (1983) DL-3,4-threo-DOPS in Parkinson\u2019s disease: effects on orthostatic hypotension and dizziness. J Neural Transm 58(3\u20134):305\u2013313","journal-title":"J Neural Transm"},{"issue":"20","key":"946_CR2","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1212\/WNL.0b013e3181c1ded6","volume":"73","author":"NI Bohnen","year":"2009","unstructured":"Bohnen NI, Muller ML, Koeppe RA, Studenski SA, Kilbourn MA, Frey KA, Albin RL (2009) History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology 73(20):1670\u20131676. doi: 10.1212\/WNL.0b013e3181c1ded6","journal-title":"Neurology"},{"issue":"14","key":"946_CR3","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1212\/WNL.0b013e3181f6128c","volume":"75","author":"KA Chung","year":"2010","unstructured":"Chung KA, Lobb BM, Nutt JG, Horak FB (2010) Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology 75(14):1263\u20131269. doi: 10.1212\/WNL.0b013e3181f6128c","journal-title":"Neurology"},{"issue":"32","key":"946_CR4","doi-asserted-by":"crossref","first-page":"13118","DOI":"10.1073\/pnas.1104614108","volume":"108","author":"RO Dror","year":"2011","unstructured":"Dror RO, Pan AC, Arlow DH, Borhani DW, Maragakis P, Shan Y, Xu H, Shaw DE (2011) Pathway and mechanism of drug binding to G-protein-coupled receptors. Proc Natl Acad Sci USA 108(32):13118\u201313123. doi: 10.1073\/pnas.1104614108","journal-title":"Proc Natl Acad Sci USA"},{"key":"946_CR5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/978-3-211-45295-0_71","volume":"70","author":"H Kaufmann","year":"2006","unstructured":"Kaufmann H (2006) The discovery of the pressor effect of DOPS and its blunting by decarboxylase inhibitors. J Neural Transm Suppl 70:477\u2013484","journal-title":"J Neural Transm Suppl"},{"issue":"Suppl 1","key":"946_CR6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10286-007-1002-2","volume":"18","author":"H Kaufmann","year":"2008","unstructured":"Kaufmann H (2008) L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience. Clin Auto Res: Off J Clin Auto Res Soc 18(Suppl 1):19\u201324. doi: 10.1007\/s10286-007-1002-2","journal-title":"Clin Auto Res: Off J Clin Auto Res Soc"},{"issue":"Suppl 1","key":"946_CR7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10286-007-1005-z","volume":"18","author":"CJ Mathias","year":"2008","unstructured":"Mathias CJ (2008) L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension: the European experience. Clin Auto Res: Off J Clin Auto Res Soc 18(Suppl 1):25\u201329. doi: 10.1007\/s10286-007-1005-z","journal-title":"Clin Auto Res: Off J Clin Auto Res Soc"},{"issue":"7","key":"946_CR8","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/FBP.0b013e32834aff98","volume":"22","author":"K McFarland","year":"2011","unstructured":"McFarland K, Price DL, Bonhaus DW (2011) Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson\u2019s disease. Behav Pharmacol 22(7):681\u2013692. doi: 10.1097\/FBP.0b013e32834aff98","journal-title":"Behav Pharmacol"},{"issue":"4","key":"946_CR9","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/npp.2009.176","volume":"35","author":"HY Meltzer","year":"2010","unstructured":"Meltzer HY, Mills R, Revell S, Williams H, Johnson A, Bahr D, Friedman JH (2010) Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of Parkinson\u2019s disease psychosis. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol 35(4):881\u2013892. doi: 10.1038\/npp.2009.176","journal-title":"Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol"},{"issue":"5\u20136","key":"946_CR10","first-page":"525","volume":"16","author":"N Ogawa","year":"1985","unstructured":"Ogawa N, Yamamoto M, Takayama H (1985) L-threo-3, 4-dihydroxyphenylserine treatment of Parkinson\u2019s disease. J Med 16(5\u20136):525\u2013534","journal-title":"J Med"},{"issue":"3","key":"946_CR11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1471-4159.2010.06635.x","volume":"113","author":"B Ouattara","year":"2010","unstructured":"Ouattara B, Gasparini F, Morissette M, Gregoire L, Samadi P, Gomez-Mancilla B, Di Paolo T (2010) Effect of l-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys. J Neurochem 113(3):715\u2013724. doi: 10.1111\/j.1471-4159.2010.06635.x","journal-title":"J Neurochem"},{"issue":"3","key":"946_CR12","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.nbd.2010.05.001","volume":"39","author":"D Rylander","year":"2010","unstructured":"Rylander D, Iderberg H, Li Q, Dekundy A, Zhang J, Li H, Baishen R, Danysz W, Bezard E, Cenci MA (2010) A mGluR5 antagonist under clinical development improves l-DOPA-induced dyskinesia in parkinsonian rats and monkeys. Neurobiol Dis 39(3):352\u2013361. doi: 10.1016\/j.nbd.2010.05.001","journal-title":"Neurobiol Dis"},{"key":"946_CR13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/B978-0-12-385952-5.00010-5","volume":"62","author":"DJ Sheffler","year":"2011","unstructured":"Sheffler DJ, Gregory KJ, Rook JM, Conn PJ (2011) Allosteric modulation of metabotropic glutamate receptors. Adv Pharmacol 62:37\u201377. doi: 10.1016\/B978-0-12-385952-5.00010-5","journal-title":"Adv Pharmacol"},{"issue":"14","key":"946_CR14","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1002\/mds.23932","volume":"26","author":"A Yarnall","year":"2011","unstructured":"Yarnall A, Rochester L, Burn DJ (2011) The interplay of cholinergic function, attention, and falls in Parkinson\u2019s disease. Mov Disord: Off J Mov Disord Soc 26(14):2496\u20132503. doi: 10.1002\/mds.23932","journal-title":"Mov Disord: Off J Mov Disord Soc"},{"key":"946_CR15","first-page":"541","volume":"69","author":"J Zoldan","year":"1996","unstructured":"Zoldan J, Friedberg G, Weizman A, Melamed E (1996) Ondansetron, a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic l-DOPA therapy in advanced Parkinson\u2019s disease. Adv Neurol 69:541\u2013544","journal-title":"Adv Neurol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-012-0946-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-012-0946-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-012-0946-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:30:22Z","timestamp":1559089822000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-012-0946-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,16]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["946"],"URL":"https:\/\/doi.org\/10.1007\/s00702-012-0946-0","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,16]]}}}